e
cancerprofessional
e
cancerpatient
English
|
Español
|
Português
My
e
Portfolio
Register
Login
Login
The email / password is invalid
Sorry, your account is currently inactive. Please contact info@ecancer.org.
Email Address
Password
Forgotten Password
Leading oncology education
|
About
e
cancer
|
Contact
|
e
cancer
club
Advanced Search
Home
Journal
Video
News
Conferences
e-learning
Projects
The latest oncology news,
research, e-learning and videos.
Category
Any
Disease areas
Patient Care
Policy
Prevention & Screening
Treatments
Sub-Category
Any
Browse
LATEST
News: Obese patients underrepresented in cancer clinical trials
News: Belief in fake causes of cancer is rife
News: Real time visualisation of radiofrequency ablation
News: Organoids reveal how a deadly brain cancer grows
News: Radiotherapy offers new treatment option for liver cancer
News: Changes in breast tissue increase cancer risk for older women
Showing:
All
News (11111)
Videos (5287)
Articles (708)
Editorials (81)
Conferences (944)
Jobs (0)
Education (173)
Filter results by:
Latest
10 per page
15 per page
30 per page
Last
132
133
134
135
136
...
1112
Next
ESMO 2017: EAPM roundtable at ESMO Congress on education, innovation and beyond
(11 Sep 2017)
ESMO 2017: Debate on duration of colon cancer adjuvant chemotherapy takes centre stage at ESMO 2017
(11 Sep 2017)
ESMO 2017: Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma
(11 Sep 2017)
ESMO 2017: KEYNOTE-040 evaluates pembrolizumab in head and neck cancer
(11 Sep 2017)
ESMO 2017: Adjuvant nivolumab superior to ipilimumab in surgically resected stage III/IV melanoma
(11 Sep 2017)
ESMO 2017: Updated results of the SCOT study
(11 Sep 2017)
ESMO 2017: FOLFOX4/XELOX in stage II–III colon cancer: efficacy and safety results
(11 Sep 2017)
ESMO 2017: Efficacy of 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for Stage III colon cancer
(11 Sep 2017)
ESMO 2017: Three versus six months’ adjuvant oxaliplatin-based chemotherapy for patients with stage III colon cancer
(11 Sep 2017)
ESMO 2017: Combined lenvatinib and pembrolizumab produces notable response rates in advanced renal carcinoma
(10 Sep 2017)
Last
132
133
134
135
136
Next
follow us
Disease areas
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Bone
Patient Care
Complementary medicine
Elderly
Nursing
Nutrition & wellbeing
Palliative
Patient empowerment
Personalised medicine
Psychosocial
Policy
Care
Economics
Global health & cancer
Low-middle income
Medicines
Organisation of cancer
Prevention
R&D
Regulatory
Science domains
Social determinants
Technology & innovation
Training & development
Prevention & Screening
Bioinformatics
Biology
Biomarkers
Causes of cancer
Control, survivorships & outcomes
Detection, diagnosis & prognosis
Devices
Diagnostics
Epidemiology & prevention
Imaging
Screening
Treatments
Antibodies & immunotherapy
Cell therapy & stem cells
Complications
Cytotoxics
Drug development
Hormones/endocrine
Radiotherapy
Supportive care
Surgery
Targeted molecules
Transplantation
Vaccines & virus
Founding partners
Founding Charities
Published by